A61K 9/0085
Brain
Official title: {Brain, e.g. brain implants; Spinal cord}
A61K9/0085 (Brain) appears on 739 US grants and 1,335 published applications in this corpus.
Search patents in A61K- Granted patents
- 739
- Published applications
- 1,335
- Assignees
- 568
- Inventors
- 2,125
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 5 | 0 |
| 2001 | 9 | 1 |
| 2002 | 8 | 14 |
| 2003 | 5 | 8 |
| 2004 | 1 | 9 |
| 2005 | 4 | 14 |
| 2006 | 3 | 15 |
| 2007 | 4 | 27 |
| 2008 | 5 | 22 |
| 2009 | 7 | 23 |
| 2010 | 16 | 39 |
| 2011 | 12 | 46 |
| 2012 | 17 | 32 |
| 2013 | 21 | 37 |
| 2014 | 28 | 58 |
| 2015 | 32 | 57 |
| 2016 | 39 | 87 |
| 2017 | 46 | 76 |
| 2018 | 31 | 79 |
| 2019 | 60 | 99 |
| 2020 | 47 | 105 |
| 2021 | 47 | 104 |
| 2022 | 54 | 84 |
| 2023 | 59 | 67 |
| 2024 | 51 | 79 |
| 2025 | 49 | 90 |
| 2026 | 32 | 63 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hydroxypropyl beta-cyclodextrin compositions and methods15 Sep 2026US 12,734,190 B2Mandos LLC
- Hydroxypropyl beta-cyclodextrin compositions and methods15 Sep 2026US 12,734,191 B2Mandos LLC
- ABCD1 for treatment of neurodisorders15 Sep 2026US 12,735,706 B2The General Hospital Corporation
- Hydroxypropyl beta-cyclodextrin compositions and methods1 Sep 2026US 12,721,860 B2Mandos LLC
- Compositions comprising a tweak ligand and methods of using same25 Aug 2026US 12,714,740 B2Children's Hospital Medical Center
- Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy8 Oct 2026US 2026/0306543 A1The McLean Hospital Corporation
- Methods of treating neurodegenerative disorders8 Oct 2026US 2026/0306669 A1
- Glucuronoxylomannan for use in central nervous system delivery24 Sep 2026US 2026/0284199 A1University of Florida Research Foundation, Inc.
- Aav vector and use thereof27 Aug 2026US 2026/0248967 A1Prodegre Therapeutics (Shangha) Co., Ltd.
- Elements for de-targeting gene expression in dorsal root ganglion and/or liver27 Aug 2026US 2026/0248968 A1Encoded Therapeutics, Inc.
Most cited
By later US patents
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Drug depot implant designs1,379US 7,727,954 B2Warsaw Orthopedic, Inc. · 2010
- Multi-dose drug delivery device and method1,352US 8,679,093 B2MicroCHIPS, Inc. · 2014
- Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body569US 5,836,935 A1998
- Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels548US 6,605,294 B2Incept, LLC · 2003